What long term changes do SSRI and SARI drugs cause?

  • Thread starter Thread starter CrimpJiggler
  • Start date Start date
  • Tags Tags
    Cause Drugs Term
AI Thread Summary
Long-term use of SSRIs primarily inhibits serotonin reuptake, potentially leading to downregulation of 5-HT receptors due to increased serotonin levels in the synapse. There is some debate regarding the downregulation of adrenergic receptors, as it seems more applicable to TCAs and SNRIs than to SSRIs. SARIs like trazodone and mirtazapine have complex interactions with various monoamine receptors, raising questions about their long-term effects. The mechanism of receptor downregulation in these cases is unclear, especially since antagonism might counteract reuptake inhibition. Overall, the long-term neurobiological impacts of these antidepressants remain a topic of ongoing inquiry.
CrimpJiggler
Messages
141
Reaction score
1
I read about long term use of these kinda antidepressants causing hippocampal neurogenesis and stuff like that but I'm focusing more on what long term use does to the various monoamine neurotransmitter pathways. I'll start with SSRIs because they are the simplest. Their main mechanism of action is inhibiting reuptake of serotonin. Would I be right in assuming that the surplus of serotonin in the synapse causes downregulation of 5-HT receptors? In my pharmacology book, they claimed that long term use of antidepressants cause downregulation of two of the subtypes (α2 and β1 I think it was) of adrenergic receptors but they didn't state what class of antidepressants do this. I can see why TCAs and other SNRIs would downregulate α and β receptors but I don't see why SSRIs would cause significant downregulation of adrenaline receptors. However, I know very little about what long term use of an SSRI does.

SARIs (serotonin antagonist reuptake inhibitors) are an even bigger mystery to me. Two that I'm familiar with are trazodone and mirtazapine. Trazodone binds strongly (and antagonises) various 5-HT receptors, as well as α1 receptors. It also has mild affinity for the serotonin transporter. Mirtazapine has a similar binding profile but its much less selective (i.e. it has significant anticholinergic and antihistamine properties). Since these drugs block various monoamine receptors, what kinda long term effects do they produce? I can't see how they would downregulate receptors (since the antagonism should counteract the reuptake inhibition) or produce long term trophic effects such as hippocampal neurogenesis.
 
Biology news on Phys.org
@BillTre may have an answer. Our neurobiology members are not very active lately.
 
https://www.discovermagazine.com/the-deadliest-spider-in-the-world-ends-lives-in-hours-but-its-venom-may-inspire-medical-miracles-48107 https://en.wikipedia.org/wiki/Versutoxin#Mechanism_behind_Neurotoxic_Properties https://www.sciencedirect.com/science/article/abs/pii/S0028390817301557 (subscription or purchase requred) he structure of versutoxin (δ-atracotoxin-Hv1) provides insights into the binding of site 3 neurotoxins to the voltage-gated sodium channel...
Popular article referring to the BA.2 variant: Popular article: (many words, little data) https://www.cnn.com/2022/02/17/health/ba-2-covid-severity/index.html Preprint article referring to the BA.2 variant: Preprint article: (At 52 pages, too many words!) https://www.biorxiv.org/content/10.1101/2022.02.14.480335v1.full.pdf [edited 1hr. after posting: Added preprint Abstract] Cheers, Tom

Similar threads

Back
Top